Molecule intelOpportunity: ModerateEssentialCrowded market

Artemether

985 brands · 298 companies · product forms

ATC: P01BE02 1 DRAP alert

Opportunity snapshot

Launch attractiveness
49
Market saturation
100
Price room
100
Regulatory risk
50
985
brands
298
companies
Rs 590.91
median price
852
price points
12.95x
price spread
100
confidence %

Who competes here

Top companies by brand count — fragmented market (no dominant player) · leader share 2%

Price room

Across observed sources and strengths
CheapestRs 130.21
MedianRs 590.91
Most expensiveRs 1,685.64
Spread12.95×
Sources: DRAP-official, DVAGO, Servaid

max/min price ratio 12.95x across 852 trusted points (Rs 130.21-1685.64). NOTE: mixes strengths (graph prices carry no strength), so treat as indicative.

Brands & products on the market

Sample of 12 live products for Artemether — each links to its own medicine page.

Regulatory alerts

Recall exposurelatest 2024-04-28
Recall Alert; Drug Products: Artecid 75mg/3mL Injections by M/s Biolabs Pvt., Ltd., Islama

Why this score

Launch attractiveness

40% supply-gap(45) + 25% price-variation(100) + 20% low-competition(0) + 15% supply-disruption(40), damped by confidence(100). Higher = more attractive, less crowded opportunity.

Market saturation

298 canonical companies and 985 brands compete (saturation pegged at 30 companies / 150 brands).

Price room

max/min price ratio 12.95x across 852 trusted points (Rs 130.21-1685.64). NOTE: mixes strengths (graph prices carry no strength), so treat as indicative.

Regulatory risk

1 DRAP alert(s), latest 2024-04-28 incl. recall/safety.

Confidence

Full coverage.

Packaged brief for this moderate opportunity?

Molecule page + company profiles + price-room analysis are the pilot package for pharma teams.

See packaged reports All 3868 molecules

Molecule intelligence as of 2026-07-30. Brand/company counts from DRAP registry and observed retail sources.

For medicine intelligence and professional reference only. Not medical advice.